Market Study on Oncology Drugs: North America Leads With Close to 50% Global Market Share

Sep 2022| PMR2026A| Persistence Market Research

Report Highlights

Oncology Drugs Market: Scope of Report

The latest publication by Persistence Market Research on the global oncology drugs market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for the global oncology drugs market and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the global oncology drugs market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the global oncology drugs market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the global oncology drugs market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the global oncology drugs market offers information divided into five important segments – drug class, indication, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

  • Chemotherapy
  • Alkylating Agents
  • Antimetabolites
  • Anti-tumour Antibiotics
  • Topoisomerase Inhibitors
  • Mitotic Inhibitors
  • Others
  • Targeted Therapy
  • Monoclonal Antibodies
  • Small Molecule Inhibitors
  • Immunotherapy
  • Immune Checkpoint Inhibitors
  • Cell Therapy and Gene Therapy
  • Oncolytic Virus Therapy
  • Cancer Vaccines
  • Immune System Modulators
  • Others
  • Hormonal Therapy

Indication

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Multiple Myeloma
  • Colorectal Cancer
  • Non-Hodgkin's Lymphoma
  • Kidney Cancer
  • Chronic lymphocytic Leukemia
  • Melanoma
  • Others

Route of Administration

  • Oral
  • Injectable

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for oncology drugs over the coming years?
  • How will changing trends impact the market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the oncology drugs market avail themselves of the growth opportunities in developed and emerging sectors?

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2032
Units considered $ Million
Segments covered Drug Class, Indication, Route Of Administration, Distribution Channel, Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa
Companies studied
GlaxoSmithKline plc.
Astrazeneca
Merck KGaA
Johnson & Johnson
Pfizer, Inc.
Bayer AG
Sanofi S.A.
Boehringer Ingelheim
Bausch Health Companies Inc.
Galderma SA
Novartis AG (Alcon)
Arbor Pharmaceuticals
Perrigo Company Plc.
Allergan
Lupin
Teva pharmaceuticals
Ultragenyx Pharmaceutical Inc
Zydus Cadila Healthcare Ltd.
Glenmark Pharmaceuticals

Frequently Asked Questions (FAQs)

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the oncology drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the oncology drugs market more accurate and reliable.

  • Table 1 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 2 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 3 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 4 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 5 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 6 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 7 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 8 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 9 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Region
  • Table 10 : Global Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Region
  • Table 11 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 12 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 13 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 14 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 15 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 16 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 17 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 18 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 19 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 20 : North America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 21 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 22 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 23 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 24 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 25 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 26 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 27 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 28 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 29 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 30 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 31 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 32 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 33 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 34 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 35 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 36 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 37 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 38 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 39 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 40 : Europe Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 41 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 42 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 43 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 44 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 45 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 46 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 47 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 48 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 49 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 50 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 51 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 52 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 53 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 54 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 55 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 56 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 57 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 58 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 59 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 60 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 61 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 62 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 63 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 64 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 65 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 66 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 67 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 68 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 69 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 70 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 71 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 72 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Country
  • Table 73 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 74 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Drug Class
  • Table 75 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 76 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Indication
  • Table 77 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 78 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Route of Administration
  • Table 79 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Table 80 : MEA Oncology Drugs Market Size (US$ Bn) Analysis 2012-2021 and Forecast 2022-2032, By Distribution Channel
  • Figure 1 : Global Oncology Drugs Market Value Share By Drug Class (2022 E)
  • Figure 2 : Global Oncology Drugs Market Value Share By Indication (2022 E)
  • Figure 3 : Global Oncology Drugs Market Value Share By Route of administration (2022 E)
  • Figure 4 : Global Oncology Drugs Market Value Share By Distribution Channel (2022 E)
  • Figure 5 : Global Oncology Drugs Market Value Share By Region (2022 E)
  • Figure 6 : Global Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 7 : Global Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 8 : Global Oncology Drugs Market Absolute $ Opportunity Analysis, 2022-2032
  • Figure 9 : Global Oncology Drugs Market Analysis by Drug Class –2021 & 2032
  • Figure 10 : Global Oncology Drugs Market Attractiveness, by Drug Class, 2022- 2032
  • Figure 11 : Global Oncology Drugs Market Analysis by Indication –2021 & 2032
  • Figure 12 : Global Oncology Drugs Market Attractiveness, By Indication, 2022- 2032
  • Figure 13 : Global Oncology Drugs Market Analysis By Route of Administration –2021 & 2032
  • Figure 14 : Global Oncology Drugs Market Attractiveness, By Route of Administration, 2022- 2032
  • Figure 15 : Global Oncology Drugs Market Analysis By Distribution Channel –2021 & 2032
  • Figure 16 : Global Oncology Drugs Market Attractiveness, By Distribution Channel, 2022- 2032
  • Figure 17 : Global Oncology Drugs Market Analysis by Region–2021 & 2032
  • Figure 18 : Global Oncology Drugs Market Attractiveness, By Region, 2022-2032
  • Figure 19 : North America Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 20 : North America Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 21 : North America Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 22 : North America Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 23 : North America Oncology Drugs Market Value Share, by Country 2022 (E)
  • Figure 24 : North America Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 25 : North America Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 26 : North America Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 27 : North America Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 28 : North America Oncology Drugs Market Attractiveness, By Indication
  • Figure 29 : North America Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 30 : North America Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 31 : U.S. Market Value Proportion Analysis, 2021
  • Figure 32 : U.S. Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 33 : U.S. Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 34 : U.S. Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 35 : U.S. Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 36 : Canada Market Value Proportion Analysis, 2021
  • Figure 37 : Canada Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 38 : Canada Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 39 : Canada Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 40 : Canada Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 41 : Latin America Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 42 : Latin America Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 43 : Latin America Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 44 : Latin America Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 45 : Latin America Oncology Drugs Market Value Share, by Country 2022 (E)
  • Figure 46 : Latin America Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 47 : Latin America Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 48 : Latin America Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 49 : Latin America Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 50 : Latin America Oncology Drugs Market Attractiveness, By Indication
  • Figure 51 : Latin America Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 52 : Latin America Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 53 : Brazil Market Value Proportion Analysis, 2021
  • Figure 54 : Brazil Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 55 : Brazil Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 56 : Brazil Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 57 : Brazil Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 58 : Mexico Market Value Proportion Analysis, 2021
  • Figure 59 : Mexico Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 60 : Mexico Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 61 : Mexico Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 62 : Mexico Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 63 : Argentina Market Value Proportion Analysis, 2021
  • Figure 64 : Argentina Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 65 : Argentina Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 66 : Argentina Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 67 : Argentina Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 68 : Europe Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 69 : Europe Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 70 : Europe Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 71 : Europe Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 72 : Europe Oncology Drugs Market Value Share, by Region 2022 (E)
  • Figure 73 : Europe Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 74 : Europe Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 75 : Europe Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 76 : Europe Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 77 : Europe Oncology Drugs Market Attractiveness, By Indication
  • Figure 78 : Europe Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 79 : Europe Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 80 : U.K. Market Value Proportion Analysis, 2021
  • Figure 81 : U.K. Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 82 : U.K. Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 83 : U.K. Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 84 : U.K. Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 85 : Germany Market Value Proportion Analysis, 2021
  • Figure 86 : Germany Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 87 : Germany Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 88 : Germany Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 89 : Germany Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 90 : Italy Market Value Proportion Analysis, 2021
  • Figure 91 : Italy Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 92 : Italy Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 93 : Italy Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 94 : Italy Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 95 : France Market Value Proportion Analysis, 2021
  • Figure 96 : France Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 97 : France Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 98 : France Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 99 : France Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 100 : Spain Market Value Proportion Analysis, 2021
  • Figure 101 : Spain Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 102 : Spain Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 103 : Spain Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 104 : Spain Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 105 : Russia Market Value Proportion Analysis, 2021
  • Figure 106 : Russia Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 107 : Russia Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 108 : Russia Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 109 : Russia Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 110 : BENELUX Market Value Proportion Analysis, 2021
  • Figure 111 : BENELUX Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 112 : BENELUX Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 113 : Spain Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 114 : BENELUX Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 115 : South Asia Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 116 : South Asia Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 117 : South Asia Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 118 : South Asia Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 119 : South Asia Oncology Drugs Market Value Share, by Region 2022 (E)
  • Figure 120 : South Asia Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 121 : South Asia Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 122 : South Asia Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 123 : South Asia Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 124 : South Asia Oncology Drugs Market Attractiveness, By Indication
  • Figure 125 : South Asia Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 126 : South Asia Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 127 : India Market Value Proportion Analysis, 2021
  • Figure 128 : India Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 129 : India Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 130 : India Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 131 : India Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 132 : Thailand Market Value Proportion Analysis, 2021
  • Figure 133 : Thailand Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 134 : Thailand Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 135 : Thailand Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 136 : Thailand Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 137 : Malaysia Market Value Proportion Analysis, 2021
  • Figure 138 : Malaysia Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 139 : Malaysia Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 140 : Malaysia Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 141 : Malaysia Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 142 : France Market Value Proportion Analysis, 2021
  • Figure 143 : France Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 144 : France Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 145 : France Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 146 : France Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 147 : East Asia Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 148 : East Asia Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 149 : East Asia Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 150 : East Asia Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 151 : East Asia Oncology Drugs Market Value Share, by Region 2022 (E)
  • Figure 152 : East Asia Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 153 : East Asia Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 154 : East Asia Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 155 : East Asia Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 156 : East Asia Oncology Drugs Market Attractiveness, By Indication
  • Figure 157 : East Asia Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 158 : East Asia Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 159 : China Market Value Proportion Analysis, 2021
  • Figure 160 : China Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 161 : China Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 162 : China Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 163 : China Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 164 : Japan Market Value Proportion Analysis, 2021
  • Figure 165 : Japan Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 166 : Japan Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 167 : Japan Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 168 : Japan Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 169 : South Korea Market Value Proportion Analysis, 2021
  • Figure 170 : South Korea Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 171 : South Korea Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 172 : South Korea Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 173 : South Korea Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 174 : Oceania Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 175 : Oceania Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 176 : Oceania Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 177 : Oceania Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 178 : Oceania Oncology Drugs Market Value Share, by Region 2022 (E)
  • Figure 179 : Oceania Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 180 : Oceania Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 181 : Oceania Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 182 : Oceania Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 183 : Oceania Oncology Drugs Market Attractiveness, By Indication
  • Figure 184 : Oceania Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 185 : Oceania Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 186 : Australia Market Value Proportion Analysis, 2021
  • Figure 187 : Australia Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 188 : Australia Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 189 : Australia Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 190 : Australia Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 191 : New Zealand Market Value Proportion Analysis, 2021
  • Figure 192 : New Zealand Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 193 : New Zealand Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 194 : New Zealand Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 195 : New Zealand Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 196 : MEA Oncology Drugs Market Value Share, by Drug Class 2022 (E)
  • Figure 197 : MEA Oncology Drugs Market Value Share, By Indication 2022 (E)
  • Figure 198 : MEA Oncology Drugs Market Value Share, By Route of Administration 2022 (E)
  • Figure 199 : MEA Oncology Drugs Market Value Share, By Distribution Channel 2022 (E)
  • Figure 200 : MEA Oncology Drugs Market Value Share, by Region 2022 (E)
  • Figure 201 : MEA Oncology Drugs Market Size (US$ Bn) Analysis, 2012-2021
  • Figure 202 : MEA Oncology Drugs Market Size (US$ Bn) & Y-o-Y Growth (%) Analysis, 2022-2032
  • Figure 203 : MEA Oncology Drugs Market Attractiveness Analysis , by Country
  • Figure 204 : MEA Oncology Drugs Market Attractiveness Analysis, by Drug Class
  • Figure 205 : MEA Oncology Drugs Market Attractiveness, By Indication
  • Figure 206 : MEA Oncology Drugs Market Attractiveness, By Route of Administration
  • Figure 207 : MEA Oncology Drugs Market Attractiveness, By Distribution Channel
  • Figure 208 : Turkey Market Value Proportion Analysis, 2021
  • Figure 209 : Turkey Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 210 : Turkey Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 211 : Turkey Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 212 : Turkey Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 213 : GCC Countries Market Value Proportion Analysis, 2021
  • Figure 214 : GCC Countries Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 215 : GCC Countries Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 216 : GCC Countries Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 217 : GCC Countries Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 218 : South Africa Market Value Proportion Analysis, 2021
  • Figure 219 : South Africa Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 220 : GCC Countries Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 221 : GCC Countries Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 222 : GCC Countries Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032
  • Figure 223 : North Africa Market Value Proportion Analysis, 2021
  • Figure 224 : North Africa Oncology Drugs Market Share Analysis (%), By Drug Class, 2021 & 2032
  • Figure 225 : North Africa Oncology Drugs Market Share Analysis (%), By Indication, 2021 & 2032
  • Figure 226 : North Africa Oncology Drugs Market Share Analysis (%), By Route of Administration, 2021 & 2032
  • Figure 227 : North Africa Oncology Drugs Market Share Analysis (%), By Distribution Channel, 2021 & 2032

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS